Vet Med - Czech, 2016, 61(9):528-532 | DOI: 10.17221/22/2016-VETMED

Effects of acetylsalicylic acid on coagulation tests and haptoglobin concentrations in rabbits with permanent transvenous pacingOriginal Paper

I. Uhrikova1, P. Scheer2, J. Hlozkova2, P. Suchy Jr.2, M. Sepsi3
1 Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic
2 Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic
3 Department of Internal Cardiology Medicine, University Hospital Brno, Brno, Czech Republic

The aim of this study was to evaluate changes in coagulation tests, haptoglobin concentrations and leukocyte counts in rabbits with right-ventricle pacing medicated with acetylsalicylic acid (ASA). Blood was collected from 35 non-anaesthetised males from the jugular vein at baseline, one and two months after pacemaker implantation. Animals were divided into two groups: non-medicated and medicated with ASA. Total leukocyte and platelet counts were measured on an automatic veterinary flow cytometry haematological analyser. Prothrombin time, activated partial thromboplastin time, fibrinogen levels and D-dimers were determined from citrated blood. We found significantly elevated activated partial thromboplastin times and prothrombin times in ASA in comparison to the control group, but not within the ASA group over time. We also observed a decrease in platelet counts in the control group over time, but not in comparison to the ASA group. No significant changes in total leukocyte counts and haptoglobin concentrations were detected. Medication with ASA may alter coagulation profiles in rabbits with permanent transvenous pacing.

Keywords: inflammation; D-dimers; pacemaker; Oryctolagus

Published: September 30, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Uhrikova I, Scheer P, Hlozkova J, Suchy P, Sepsi M. Effects of acetylsalicylic acid on coagulation tests and haptoglobin concentrations in rabbits with permanent transvenous pacing. Vet Med - Czech. 2016;61(9):528-532. doi: 10.17221/22/2016-VETMED.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Amann R, Peskar BA (2002): Anti-inflammatory effects of aspirin and sodium salicylate. European Journal of Pharmacology 447, 1-9. Go to original source... Go to PubMed...
    2. Balli M, Cetin M, Tasolar H, Tekin K, Cagliyan CE, Turkmen S, Uysal OK, Cayli M (2014): Increased ventricular pacing threshold levels in patients with high serum uric acid levels. Journal of Cardiology 64, 207-210. Go to original source... Go to PubMed...
    3. Costa R, Da Silva KR, Rached R, Martinelli Filho M, Carnevale FC, Moreira LF, Stolf NA (2009): Prevention of venous thrombosis by warfarin after permanent transvenous leads implantation in high-risk patients. Pacing and Clinical Electrophysiology 32, S247-S251. Go to original source... Go to PubMed...
    4. Cray C, Zaias J, Altman NH (2009): Acute phase response in animals: A review. Comparative Medicine 59, 517-526.
    5. Fazio S, Santomauro M, Cittadini A, Ferraro S, Lucariello A, Maddalena G, Sacca L (1991): Efficacy of ticlopidine in the prevention of thromboembolic events in patients with VVI pacemakers. Pacing and Clinical Electrophysiology 14, 168-173. Go to original source... Go to PubMed...
    6. Ito T, Tanouchi J, Kato J, Nishino M, Iwai K, Tanahashi H, Hori M, Yamada Y, Kamada T (1997): Prethrombotic state due to hypercoagulability in patients with permanent transvenous pacemakers. Angiology 48, 901-906. Go to original source... Go to PubMed...
    7. Jethanandani P, Sharma K, Susheela AK (1995): Circulating haptoglobin of rabbits after acute and chronic fluoride toxicity. Medical Science Research 23, 301-303.
    8. Khairy P, Landzberg MJ, Gatzoulis MA, Mercier LA, Fernandes SM, Cote JM, Lavoie JP, Fournier A, Guerra PG, Frogoudaki A, Walsh EP, Dore A (2006): Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: a multicenter study. Circulation 113, 391-397. Go to original source... Go to PubMed...
    9. Korkeila P, Nyman K, Ylitalo A, Koistinen J, Karjalainen P, Lund J, Airaksinen KE (2007): Venous obstruction after pacemaker implantation. Pacing and Clinical Electrophysiology 30, 199-206. Go to original source... Go to PubMed...
    10. Korkeila P, Mustonen P, Koistinen J, Nyman K, Ylitalo A, Karjalainen P, Lund J, Airaksinen J (2010): Clinical and laboratory risk factors of thrombotic complications after pacemaker implantation: a prospective study. Europace 12, 814-824. Go to original source... Go to PubMed...
    11. Lelakowski J, Domagala TB, Rydlewska A, Januszek R, Kotula-Horowitz K, Majewski J, Zabek A, Malecka B, Musial J (2012a): Effect of selected prothrombotic and proinflammatory factors on the incidence of venous thrombosis after pacemaker implantation. Kardiologia Polska 70, 260-267.
    12. Lelakowski J, Domagala TB, Rydlewska A, Januszek R, Kotula-Horowitz K, Majewski J, Zabek A, Malecka B (2012b): Relationship between changes in selected thrombotic and inflammatory factors, echocardiographic parameters and the incidence of venous thrombosis after pacemaker implantation based on our own observations. Archieves of Medical Science 8, 1027-1034. Go to original source... Go to PubMed...
    13. Li X, Ze F, Wang L, Li D, Duan J, Guo F, Yuan C, Li Y, Guo J (2014): Prevalence of venous occlusion in patients referred for lead extraction: implications for tool selection. Europace 16, 1795-1799. Go to original source... Go to PubMed...
    14. Noheria A, Ponamgi SP, Desimone CV, Vaidya VR, Aakre CA, Ebrille E, Hu T, Hodge DO, Slusser JP, Ammash NM, Bruce CJ, Rabinstein AA, Friedman PA, Asirvatham SJ (2016): Pulmonary embolism in patients with transvenous cardiac implantable electronic device leads. Europace. Advance online publication 18, 246-252. Go to original source... Go to PubMed...
    15. Panda RK, Malaviya AN, Sampathkumar A, Iyer KS, Das B, Sharma ML, Venugopal P (1987): Serial estimation of Creactive protein following cardiac surgery. Indian Journal of Thoracic and Cardiovascular Surgery 5, 18-23. Go to original source...
    16. Saghazadeh A, Hafizi S, Rezaei N (2015): Inflammation in venous thromboembolism: Cause or consequence? International Immunopharmacology 28, 655-665. Go to original source... Go to PubMed...
    17. Stoney WS, Addlestone RB, Alford Jr WC, Burrus GR, Frist RA, Thomas Jr CS (1976): The incidence of venous thrombosis following long-term transvenous pacing. The Annals of Thoracic Surgery 22, 166-170. Go to original source... Go to PubMed...
    18. van Rooden CJ, Molhoek SG, Rosendaal FR, Schalij MJ, Meinders AE, Huisman MV (2004): Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads. Journal of Cardiovascular Electrophysiology 15, 1258-1262. Go to original source... Go to PubMed...
    19. Zaca V, Marcucci R, Parodi G, Limbruno U, Notarstefano P, Pieragnoli P, Di Cori A, Bongiorni MG, Casolo G (2015): Management of antithrombotic therapy in patients undergoing electrophysiological device surgery. Europace 17, 840-854. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content